Hemodialysis clinical trials

Explore recruiting hemodialysis clinical trials.

Recruiting hemodialysis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hemodialysis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CLEARTOX: Development of an innovative haemodialysis method to improve dialytic clearance of protein-bound uraemic toxins

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 Open-Label Study to Evaluate the Safety and Efficacy of DCR-PHXC in Patients With Primary Hyperoxaluria Type 1 and Severe Renal Impairment, With or Without Dialysis

Germany, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

SGLT2 INHIBITION (DAPAGLIFLOZIN) IN DIABETIC AND NON-DIABETIC HEMODIALYSIS PATIENTS WITH AND WITHOUT RESIDUAL URINE VOLUME: A PROSPECTIVE RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED PHASE II TRIAL

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

PROPHYLACTIC ANTIBIOTIC TREATMENT IN END-STAGE KIDNEY DISEASE AND CENTRAL VENOUS CATHETER AS HEMODIALYSIS VASCULAR ACCESS

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF MIGALASTAT HCL IN SUBJECTS WITH FABRY DISEASE AND AMENABLE GLA VARIANTS AND SEVERE RENAL IMPAIRMENT OR END-STAGE RENAL DISEASE TREATED WITH HEMODIALYSIS

Spain, France, Portugal

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of the effect of tacrolimus on carbohydrate metabolism in pre-renal transplantation dialysis patients

France

Therapeutic use (Phase IV) EU CTIS Study details

Hemodialysis trials by city

Hemodialysis in Toronto Hemodialysis in Vancouver Hemodialysis in Montreal Hemodialysis in Calgary Hemodialysis in Edmonton Hemodialysis in Ottawa Hemodialysis in Winnipeg Hemodialysis in Quebec City Hemodialysis in Hamilton Hemodialysis in Kitchener Hemodialysis in London Hemodialysis in Halifax Hemodialysis in New York Hemodialysis in Los Angeles Hemodialysis in Chicago Hemodialysis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease